NIH-funded research R01 grant

Understanding how enterococci bacteria resist antibiotics

Official title: Role and regulation of intracellular signaling in enterococcal antimicrobial resistance

Funded at Medical College of Wisconsin · NIH-11015066 · Data updated 2026-11-12

This study is looking into how certain bacteria that can cause serious infections in hospitals become resistant to antibiotics, specifically focusing on how their internal signals help them resist treatment, with the hope of finding new ways to help patients get better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin
NIH-funded
Lab location1 site (Milwaukee, United States)
Project startFebruary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$630,730
NIH project number5R01AI175261-02
Project IDNIH-11015066 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients who have infections caused by enterococci, particularly those that are resistant to standard antibiotic treatments.

Less likely to help

Patients with infections caused by bacteria other than enterococci may not receive benefit from this research.

What this research studies

This research investigates the mechanisms behind antibiotic resistance in enterococci, which are bacteria that can cause serious hospital-acquired infections. The study focuses on the role of intracellular signaling and how it regulates the bacteria's resistance to cephalosporins, a common class of antibiotics. By exploring the genetic and biochemical factors that contribute to this resistance, the research aims to identify new therapeutic targets. Patients may benefit from improved treatment options if new strategies to combat these resistant infections are developed.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments for infections caused by antibiotic-resistant enterococci.

How similar studies have gone: Other research has shown promise in understanding antibiotic resistance mechanisms, but this specific approach focusing on intracellular signaling in enterococci is relatively novel.

Where this research is happening

  • Medical College of Wisconsin
    Milwaukee, United States
    Active

Researchers

  • Principal investigator: Kristich, Christopher J — Medical College of Wisconsin
  • Study coordinator: Kristich, Christopher J

Related research

Other NIH-funded projects on the same topics.

  • Finding a cure for sickle cell disease

    The Cure Sickle Cell Initiative is bringing together patients, families, and caregivers to work together on finding a cure for sickle cell disease using safe genetic therapies, with the goal of improving lives and speeding up the development of new treatments.

    NIH research Medical College of Wisconsin · Milwaukee, United States · NIH-9787629

  • A portable device to measure radiation dose and exposure uniformity after a large radiation event

    A field-ready, nail-based device uses advanced spectroscopy and smart software to quickly estimate how much radiation a person has received and how evenly they were exposed, within minutes.

    NIH research Medical College of Wisconsin · Milwaukee, United States · NIH-11552312

  • Ethics of Engaging Patient Groups in Drug Development for Rare Diseases

    This grant asks how patient and family groups can ethically help shape rare-disease drug development from idea to market, with input from patients, families, doctors, and researchers.

    NIH research Medical College of Wisconsin · Milwaukee, United States · NIH-11530731

  • Renovation of the Biophysics Resources at MCW

    This grant funds upgrading a core biophysics facility at the Medical College of Wisconsin to support advanced research in human biology.

    NIH research Medical College of Wisconsin · Milwaukee, United States · NIH-11520941

  • Cure Sickle Cell: Advancing Gene Therapies for Sickle Cell Disease

    A national initiative to move safer genetic therapies for sickle cell disease forward with patient, caregiver, and advocate involvement.

    NIH research Medical College of Wisconsin · Milwaukee, United States · NIH-11516405

  • Health insurance transitions for older adults with HIV on Medicare

    Older adults with HIV face complex Medicare coverage that can affect access to HIV treatment and care.

    NIH research Medical College of Wisconsin · Milwaukee, United States · NIH-11479146

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.